Tilray Inc (NASDAQ:TLRY)
| 19.53 Delayed Data As of 4:00pm ET |  +0.97 / +5.23%Today’s Change | 15.01 Today|||52-Week Range 89.88 | +14.01% Year-to-Date |
Latest TLRY News | Press Releases
| 1 Thing That Can Help Both Tilray and Canopy Growth Turn Things Around 6:57am / MotleyFool.com - Paid Partner Content | Why CBD Stocks Could Soon Skyrocket Jan 24 / MotleyFool.com - Paid Partner Content |
| Weekly Cannabis Stock News: Aphria, HEXO, and Cresco Labs Find Fresh Capital Jan 26 / MotleyFool.com - Paid Partner Content | Weekly Cannabis Stock News: Tilray Taps New Top Managers Jan 21 / MotleyFool.com - Paid Partner Content |
| Is Aphria Stock a Strong Buy Right Now? Jan 26 / MotleyFool.com - Paid Partner Content | Is Aurora a Buy at Under $2? Jan 19 / MotleyFool.com - Paid Partner Content |
| The 10 Largest Canadian Marijuana Stocks Jan 25 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 18.56 |
| Today’s open | 19.07 |
| Day’s range | 18.66 - 19.68 |
| Volume | 2,322,125 |
| Average volume (3 months) | 2,355,639 |
| Market cap | $2.0B |
Data as of 4:00pm ET, 01/28/2020
Growth & Valuation
| Earnings growth (last year) | -873.51% |
| Earnings growth (this year) | -71.93% |
| Earnings growth (next 5 years) | -4.56% |
| Revenue growth (last year) | +110.00% |
| P/E ratio | NM |
| Price/Sales | 135.76 |
| Price/Book | 9.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | +1.25 | +5.14% |
| XNCRXencor Inc | +0.77 | +2.35% |
| ALECAlector Inc | -1.14 | -4.43% |
| EPZMEpizyme Inc | +0.45 | +2.11% |
Data as of 4:00pm ET, 01/28/2020
Financials
| Next reporting date | March 23, 2020 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $43.1M |
| Annual profit (last year) | -$67.7M |
| Net profit margin | -157.02% |
Profile
Sector Process Industries |
Industry Agricultural Commodities/Milling |
No executives to display |
Corporate headquarters Nanaimo, British Columbia |
Forecasts
